Evidence map›Paper›PMID 31064863›Full record

ReviewBiochemical Society transactions2019

Engineering quorum quenching enzymes: progress and perspectives.

Shereen A Murugayah, Monica L Gerth

Abstract readReview
In one paragraph

Review in Biochemical Society transactions, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. UnderstandingMicroorganisms · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Quorum-quenching potential of recombinant PvdQ-engineered bacteria for biofilm formation.International microbiology : the official journal of the Spanish Society for Microbiology · 2023
    Article
  18. Metabolomic Analysis of the Effect ofAntibiotics (Basel, Switzerland) · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shereen A MurugayahDepartment of Biochemistry, University of Otago, Dunedin, New Zealand.
Monica L GerthMaurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand monica.gerth@vuw.ac.nz.ORCID 0000-0002-7959-7852

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quorum sensing is a key contributor to the virulence of many important plant, animal and human pathogens. The disruption of this signalling-a process referred to as 'quorum quenching'-is a promising new approach for controlling microbial pathogens. In this mini-review, we have focused on efforts to engineer enzymes that disrupt quorum sensing by inactivating acyl-homoserine lactone signalling molecules. We review different approaches for protein engineering and provide examples of how these engineering approaches have been used to tailor the stability, specificity and activities of quorum quenching enzymes. Finally, we grapple with some of the issues around these approaches-including the disconnect between

Indexed as

Protein EngineeringQuorum Sensing4-ButyrolactoneEnzymesSignal Transduction4-ButyrolactoneEnzymeshomoserine lactoneacylaseacyl-homoserine lactonelactonaseprotein engineeringquorum quenchingquorum sensing

Identifiers

PMID31064863
PMCPMC6599154

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.